Sell Your Lab as a Complete Asset Package

Yes. A whole-lab package sale is one of the paths we evaluate, alongside individual equipment resale, consignment, and auction. We help you compare expected outcomes for each approach so you can decide which fits your timeline and recovery goals.

Not always. A package sale can work well when a buyer wants an existing operational footprint and is willing to pay for the convenience of a turnkey setup. For other equipment — especially high-demand analytical instruments — individual resale, consignment, or auction often realizes more value. Most projects end up using a mix, with a package-sale attempt running in parallel with a liquidation fallback plan.

Yes. We work with clinical diagnostic labs, biotech R&D labs, pharma labs, university and research labs, analytical testing labs, cannabis/hemp testing labs, and industrial or QC labs. Our role is the equipment, valuation, buyer marketing, and sale coordination — not the clinical operating business itself.

Lease assignment or sublease, business sale, ownership transfer, and accreditation/licensing transfers (CLIA, COLA, CAP, state licenses, payer enrollment, permits) are separate matters handled by the appropriate parties and qualified professionals — not by pForm. Transferability is never guaranteed and is subject to landlord, regulatory, and third-party approval. Any information about accreditation, licensing, enrollment, lease terms, or revenue shared during a sale process is seller-reported and subject to independent buyer due diligence.

Not necessarily to start. We provide a commercial recovery estimate based on the asset list, condition, and current buyer demand — useful for planning, not a certified appraisal. If you need a formal appraisal for tax, accounting, financing, or legal purposes, we can refer qualified appraisers; that is outside our scope.

Yes. We typically run whole-lab sale processes through a confidential listing package — asset schedules and photos without identifying the facility — and require an NDA before releasing identifying details or arranging buyer walkthroughs.

We build a fallback plan into every whole-lab engagement from the start. If no qualified buyer emerges for the full package within an agreed window, we shift to individual equipment resale, consignment, or auction so the project keeps moving toward your deadline.

In some cases, yes — direct purchase is one of the disposition options we offer when a fast, predictable exit matters more than maximizing every dollar. We'll tell you upfront whether direct purchase is a fit for your asset mix or whether a managed sale process will likely perform better.

Many lab assets — particularly those exposed to biological, chemical, or radiological materials — need decontamination before sale or removal, and buyers increasingly expect documentation of it. We can help plan and coordinate decontamination through qualified vendors. We do not perform regulated decontamination, hazardous waste disposal, or environmental remediation ourselves.

Yes. We can inspect, document, and organize your laboratory assets — condition, photos, major-equipment identification, missing accessories, available service records — to build buyer-ready asset schedules. This is an asset documentation review, not a regulatory compliance certification, environmental clearance, biosafety certification, or engineering inspection.

Yes, in a coordination capacity. We can help plan decontamination and closeout sequencing, coordinate with hazardous waste and environmental vendors, and align asset removal with your facility turnover or landlord handback date. Regulated decontamination, hazardous waste disposal, and environmental remediation must be performed by separately authorized, licensed, and insured vendors — we coordinate, we don't perform that work ourselves.